Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRx-191 in plaque psoriasis
2006-005848-87Phase 2Completed
- Sponsor
- CombinatoRx
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CRx-191 in plaque psoriasis (6 arms), sponsored by CombinatoRx. Primary endpoint: Change in psoriatic infiltrate band thickness at Day 12. Started Jul 2007; status: completed.
02
Drugs
CRx-191
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2006-005848-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005848-87.